Su ZY, Siak PY, Lwin YY, Cheah SC. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer Metastasis Rev. 2024;43(3):919–39. https://doi.org/10.1007/s10555-024-10176-9

Article  PubMed  Google Scholar 

Badoual C. Update from the 5th edition of the world health organization classification of head and neck tumors: oropharynx and nasopharynx. Head Neck Pathol. 2022;16(1):19–30. https://doi.org/10.1007/s12105-022-01449-2

Article  PubMed  PubMed Central  Google Scholar 

Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1765–77. https://doi.org/10.1158/1055-9965.EPI-06-0353

Article  CAS  PubMed  Google Scholar 

Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80. https://doi.org/10.1016/S0140-6736(19)30956-0

Article  PubMed  Google Scholar 

Dong H, Huang Z, Yang D, Li Z, Huang H, Meng Z, Qin Y, Kang M. Prognostic value of EBV DNA and platelet-to-lymphocyte ratio in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study. BMC Cancer. 2023;23(1):673. https://doi.org/10.1186/s12885-023-11117-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo LF, Hong JG, Wang RJ, Chen GP, Wu SG. Nasopharyngeal carcinoma survival by histology in endemic and non-endemic areas. Ann Med. 2024;56(1):2425066. https://doi.org/10.1080/07853890.2024.2425066

Article  PubMed  PubMed Central  Google Scholar 

Xu M, Zang J, Luo S, Wang J, Li X. Long-term survival outcomes and adverse effects of nasopharyngeal carcinoma patients treated with IMRT in a non-endemic region: a population-based retrospective study. BMJ Open. 2021;11(8):e045417. https://doi.org/10.1136/bmjopen-2020-045417

Article  PubMed  PubMed Central  Google Scholar 

Argirion I, Zarins KR, Ruterbusch JJ, Vatanasapt P, Sriplung H, Seymour EK, Rozek LS. Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the united States. Cancer. 2020;126(1):121–30. https://doi.org/10.1002/cncr.32517

Article  PubMed  Google Scholar 

van Velsen JS, van der Vegt B, Plaat BEC, Langendijk JA, Epskamp-Kuijpers CCHJ, van Dijk BAC, Oosting SF. Nasopharyngeal carcinoma: nationwide trends in subtype-specific incidence and survival over 3 decades in a non-endemic area. J Cancer Res Clin Oncol. 2024;150(2):49. https://doi.org/10.1007/s00432-023-05547-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Neo J, Yip PL, Ong EHW, Miao J, Chow WM, Wee JTS, Fong KW, Soong YL, Tan TWK, Tan JSH, Sin SY, Liu J, Loh KS, Tay JK, Ang MK, Tan SH, Lim DWT, Chua MLK. Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma. Oral Oncol. 2024;148:106655. https://doi.org/10.1016/j.oraloncology.2023.106655

Article  CAS  PubMed  Google Scholar 

Liu X, Zhang Y, Yang KY, Zhang N, Jin F, Zou GR, Zhu XD, Xie FY, Liang XY, Li WF, He ZY, Chen NY, Hu WH, Wu HJ, Shi M, Zhou GQ, Mao YP, Guo R, Sun R, Huang J, Liang SQ, Wu WL, Su Z, Li L, Ai P, He YX, Zang J, Chen L, Lin L, Huang SH, Xu C, Lv JW, Li YQ, Hong SB, Jie YS, Li H, Huang SW, Liang YL, Wang YQ, Peng YL, Zhu JH, Zang SB, Liu SR, Lin QG, Li HJ, Tian L, Liu LZ, Zhao HY, Lin AH, Li JB, Liu N, Tang LL, Chen YP, Sun Y, Ma J. Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial. Lancet. 2024;403(10445):2720–31. https://doi.org/10.1016/S0140-6736(24)00594-4

Article  CAS  PubMed  Google Scholar 

Liu GY, Ye YF, Jiang YF, Chen GJ, Xia WX, Huang YS, Gao TS, Liu YM, Hou YT, Li JF, Liu JH, Lu N, Chen CL, Ke LR, Liang H, Bei WX, Li WZ, Dong SH, Liu Q, Xie C, Yao HR, Xiang YQ. Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial. BMJ. 2024;385:e077890. https://doi.org/10.1136/bmj-2023-077890

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang CL, Zhang N, Jiang W, Xie FY, Pei XQ, Huang SH, Wang XY, Mao YP, Li KP, Liu Q, Li JB, Liang SQ, Qin GJ, Hu WH, Zhou GQ, Ma J, Sun Y, Chen L, Tang LL. Reduced-Volume irradiation of uninvolved neck in patients with nasopharyngeal cancer: updated results from an Open-Label, noninferiority, multicenter, randomized phase III trial. J Clin Oncol. 2024;42(17):2021–5. https://doi.org/10.1200/JCO.23.02086

Article  CAS  PubMed  Google Scholar 

Wang Q, Xie H, Li Y, Theodoropoulos N, Zhang Y, Jiang C, Wen C, Rozek LS, Boffetta P. Racial and ethnic disparities in nasopharyngeal cancer with an emphasis among Asian Americans. Int J Cancer. 2022;151(8):1291–303. https://doi.org/10.1002/ijc.34154

Article  CAS  PubMed  Google Scholar 

Chan AT, Teo ML, Lee WY, Kwan WH, Choi PH, Johnson PJ. The significance of keratinizing squamous cell histology in Chinese patients with nasopharyngeal carcinoma. Clin Oncol (R Coll Radiol). 1998;10(3):161–4. https://doi.org/10.1016/s0936-6555(98)80057-5

Article  CAS  PubMed  Google Scholar 

Ou SI, Zell JA, Ziogas A, Anton-Culver H. Epidemiology of nasopharyngeal carcinoma in the united States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol. 2007;18(1):29–35. https://doi.org/10.1093/annonc/mdl320

Article  PubMed  Google Scholar 

Zhao LN, Zhou B, Shi M, Wang JH, Xiao F, Xu M, Luo SQ, Xue Y, Li JP, Tan LN. Clinical outcome for nasopharyngeal carcinoma with predominantly WHO II histology treated with intensity-modulated radiation therapy in non-endemic region of China. Oral Oncol. 2012;48(9):864–9. https://doi.org/10.1016/j.oraloncology.2012.03.001

Article  PubMed  Google Scholar 

Zheng H, Zhou P, Wang J, Yu YF, Zhou R, Lin Q, Wu SG. Prognostic effect of residual plasma Epstein-Barr viral DNA after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Cancer Med. 2023;12(14):14979–87. https://doi.org/10.1002/cam4.6132

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu B, Sun M, Wang Z, Zheng Y, Cai W, Shi HH, Zhuang Y, Lin Q. Prognostic value of programmed cell Death-Ligand 1 expression in Tumor-Infiltrating lymphocytes and viral load in peripheral blood mononuclear cells for Epstein-Barr Virus-Positive nasopharyngeal carcinoma. Clin Chem. 2020;66(9):1219–27. https://doi.org/10.1093/clinchem/hvaa170

Article  PubMed  Google Scholar 

Guo SS, Yang JH, Sun XS, Liu LZ, Yang ZC, Liu LT, Liu SL, Li XY, Lv XF, Luo DH, Li JB, Liu Q, Wang P, Guo L, Mo HY, Sun R, Yang Q, Liang YJ, Jia GD, Zhao C, Chen QY, Tang LQ, Mai HQ. Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial. Eur J Cancer. 2023;194:113336. https://doi.org/10.1016/j.ejca.2023.113336

Article  CAS  PubMed  Google Scholar 

Liu LT, Liang YJ, Guo SS, Xie Y, Jia GD, Wen DX, Tang LQ, Chen QY, Mai HQ. Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein-Barr virus DNA. Head Neck. 2022;44(1):34–45. https://doi.org/10.1002/hed.26897

Article  CAS  PubMed  Google Scholar 

Liang YJ, Wen DX, Luo MJ, Tang LQ, Guo SS, Wang P, Chen QY, Liu LT, Mai HQ. Induction or adjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in paediatric nasopharyngeal carcinoma in the IMRT era: A recursive partitioning risk stratification analysis based on EBV DNA. Eur J Cancer. 2021;159:133–43. https://doi.org/10.1016/j.ejca.2021.09.045

Article  CAS  PubMed  Google Scholar 

Tang LL, Guo R, Zhang N, Deng B, Chen L, Cheng ZB, Huang J, Hu WH, Huang SH, Luo WJ, Liang JH, Zheng YM, Zhang F, Mao YP, Li WF, Zhou GQ, Liu X, Chen YP, Xu C, Lin L, Liu Q, Du XJ, Zhang Y, Sun Y, Ma J. Effect of radiotherapy alone vs radiotherapy with concurrent chemoradiotherapy on survival without disease relapse in patients with Low-risk nasopharyngeal carcinoma: A randomized clinical trial. JAMA. 2022;328(8):728–36. https://doi.org/10.1001/jama.2022.13997

Article  PubMed  PubMed Central  Google Scholar 

Wu SG, Lian CL, Wang J, Zhang WW, Sun JY, Lin Q, He ZY. The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow up. Ann Transl Med. 2019;7(23):768. https://doi.org/10.21037/atm.2019.11.75

Article  PubMed  PubMed Central  Google Scholar 

Kanno M, Narita N, Fujimoto Y, Wakisaka N, Yoshizaki T, Kodaira T, Makita C, Sato Y, Yamazaki K, Wakaoka T, Shimode Y, Tsuji H, Kito R, Ishinaga H, Hosokawa S, Takakura H, Nishimura K, Matoba T, Fujieda S. Third epidemiological analysis of nasopharyngeal carcinoma in the central region of Japan from 2006 to 2015. Cancers (Basel). 2019;11(8):1180. https://doi.org/10.3390/cancers11081180

Article